日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Adjuvant capecitabine in patients with triple-negative breast cancer after neoadjuvant chemotherapy

新辅助化疗后三阴性乳腺癌患者接受卡培他滨辅助治疗

Strahan, A; Jin, Q; Raghavendra, A S; Zakon, D B; Grimm, M; Hughes, M E; Cherian, M; Vincuilla, J; Parker, T; Tarantino, P; Johnson, K C C; Mittendorf, E A; King, T A; Valero, V; Tripathy, D; Tolaney, S M; Tayob, N; Lin, N U; Stover, D G; Barcenas, C H; Garrido-Castro, A C

Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy according to HER2-low status☆

根据HER2低表达状态评估新辅助化疗后早期三阴性乳腺癌的临床结果☆

Raghavendra, A S; Zakon, D B; Jin, Q; Strahan, A; Grimm, M; Hughes, M E; Cherian, M; Vincuilla, J; Parker, T; Tarantino, P; Mittendorf, E A; King, T A; Valero, V; Tripathy, D; Tolaney, S M; Tayob, N; Lin, N U; Stover, D G; Barcenas, C H; Garrido-Castro, A C

Distress and inflammation are independently associated with cancer-related symptom severity

痛苦和炎症与癌症相关症状的严重程度独立相关。

Lacourt, Tamara E; Tripathy, D; Swartz, Maria C; LaVoy, Emily C; Heijnen, Cobi J

Infrared thermography in the diagnosis of palmar hyperhidrosis: A diagnostic study

红外热成像技术在手掌多汗症诊断中的应用:一项诊断研究

Neema, Shekhar; Tripathy, D M; Mukherjee, Sweta; Sinha, Anwita; Vendhan, Senkadhir; Vasudevan, Biju

Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancer before chemo-endocrine therapy

化疗-内分泌治疗前,预测II-III期激素受体阳性、HER2阴性(HR+/HER2-)乳腺癌对内分泌治疗的敏感性

Du, L; Yau, C; Brown-Swigart, L; Gould, R; Krings, G; Hirst, G L; Bedrosian, I; Layman, R M; Carter, J M; Klein, M; Venters, S; Shad, S; van der Noordaa, M; Chien, A J; Haddad, T; Isaacs, C; Pusztai, L; Albain, K; Nanda, R; Tripathy, D; Liu, M C; Boughey, J; Schwab, R; Hylton, N; DeMichele, A; Perlmutter, J; Yee, D; Berry, D; Van't Veer, L; Valero, V; Esserman, L J; Symmans, W F

Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival

新辅助治疗后乳腺癌患者的循环肿瘤DNA反映了治疗反应和生存情况。

Magbanua, M J M; Swigart, L B; Wu, H-T; Hirst, G L; Yau, C; Wolf, D M; Tin, A; Salari, R; Shchegrova, S; Pawar, H; Delson, A L; DeMichele, A; Liu, M C; Chien, A J; Tripathy, D; Asare, S; Lin, C-H J; Billings, P; Aleshin, A; Sethi, H; Louie, M; Zimmermann, B; Esserman, L J; van 't Veer, L J

Combined pericapsular nerve group and lateral femoral cutaneous nerve blocks for surgical anaesthesia in hip arthroscopy

髋关节镜手术麻醉中采用关节囊周围神经群和股外侧皮神经联合阻滞

Talawar, Praveen; Tandon, Shipra; Tripathy, D K; Kaushal, Ashutosh

Comparative efficacy of adjuvant trastuzumab-containing chemotherapies for patients with early HER2-positive primary breast cancer: a network meta-analysis

辅助曲妥珠单抗化疗治疗早期HER2阳性原发性乳腺癌患者的疗效比较:一项网络荟萃分析

Shen, Y; Fujii, T; Ueno, N T; Tripathy, D; Fu, N; Zhou, H; Ning, J; Xiao, L

Progression-free survival (PFS) and toxicities of palbociclib in a geriatric population

帕博西尼在老年人群中的无进展生存期(PFS)和毒性

Clifton, K; Min, Yi; Kimmel, J; Litton, J; Tripathy, D; Karuturi, M

Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with adjuvant doxorubicin and cyclophosphamide (SWOG S9313)

同源重组缺陷生物标志物对接受辅助多柔比星和环磷酰胺治疗的三阴性乳腺癌患者预后的影响(SWOG S9313)

Sharma, P; Barlow, W E; Godwin, A K; Pathak, H; Isakova, K; Williams, D; Timms, K M; Hartman, A R; Wenstrup, R J; Linden, H M; Tripathy, D; Hortobagyi, G N; Hayes, D F